FIELD: medicine.
SUBSTANCE: method involves carrying out cytological study of biopsy material. The treatment is considered to be effective, if polynuclear hystiocytes and reactive fibrocytes changes are detected in tissue under study. 4-6 months later, reactively changed thyroid gland epithelium is detected and in 7-9 months, thyroid gland tissue regeneration is observed in biopsy material. The treatment is considered to be ineffective, if no said changes are observed at some of cytological study stages.
EFFECT: enabled treatment effectiveness estimation; differentially based necessity of repeated intervention; simplified method.
6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS FOR NODAL FORMS OF THYROID GLAND DISEASES | 2004 |
|
RU2251991C1 |
| METHOD OF TWO-STAGE COMBINED DESTRUCTION OF BENIGN THYROID NODULES | 2009 |
|
RU2402359C1 |
| DEVICE FOR TREATMENT OF BENIGN THYROID NODULES AND METHOD OF ITS USE | 2020 |
|
RU2747072C1 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH TO DIFFERENTIATED THYROID CARCINOMA COMBINED WITH HASHIMOTO'S THYROIDITIS WITH JUNCTION | 2013 |
|
RU2522388C1 |
| METHOD OF SURGICAL MANAGEMENT OF BENIGN PALPABLE THYROID ABNORMALITIES | 2010 |
|
RU2438604C1 |
| METHOD FOR TWO-STAGE TREATMENT OF NODULAR TOXIC GOITER | 2023 |
|
RU2820877C1 |
| METHOD FOR TREATING BENIGN SOLID THYROID NODULES | 2021 |
|
RU2774595C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HIGH DIFFERENTIATED CANCER IN PATIENTS WITH NODULAR FORMS OF THYROID DISEASES | 2014 |
|
RU2553378C1 |
| 0 |
|
SU1779222A3 | |
| METHOD OF TREATING PALPABLE BENIGN BREAST ABNORMALITIES | 2008 |
|
RU2381765C1 |
